Healthcare
August 31, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee and vocal advocate for science-led development of safe, affordable, COVID-19 vaccines and treatments, reacted to Food and Drug Administration (FDA) Commissioner Stephen Hahn telling the Financial Times that “his agency was prepared to authorise a vaccine before Phase Three clinical trials were complete,” raising concerns of political interference. Rep. Doggett’s statement:
August 20, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, joined with U.S. Representative Katie Porter (D-CA), a member of the House Committee on Oversight and Reform, to press the Trump Administration for answers on how HHS is protecting the taxpayer investment in funding and procurement agreements for Moderna’s COVID-19 vaccine.
August 11, 2020
President Donald Trump said Tuesday the U.S. government will purchase 100 million doses of a coronavirus vaccine candidate from biotech company Moderna that is currently undergoing clinical trials.
August 7, 2020
As the pandemic broadens and President Trump insists on rushing the short timeline for a COVID-19 vaccine, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, joined with Representative Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, and eleven other members of Congress to press the Trump Administration for a comprehensive accounting and progress report on precisely how much taxpayer money has been poured into the COVID-19 vaccine efforts so far and how it is being used.
August 6, 2020
U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to President Trump’s executive order on manufacturing today:
Image
August 5, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to the admission by Moderna today that “Moderna has not been living up to contractual obligations to disclose the percentage of taxpayer dollars that are funding its coronavirus vaccine project, but the pharmaceutical company tells Axios that federal money makes up ‘100% funding of the program.’” His statement:
August 5, 2020
Moderna will charge between $32 and $37 a dose for its experimental coronavirus vaccine for some "low volume" customers, the company's CEO said Wednesday. With the likelihood of two doses needed, that could be almost $80 per course of treatment.
July 24, 2020
Following President Trump’s announcement of four executive orders concerning prescription drug prices, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, issued the following statement
Issues:Healthcare
July 24, 2020
The Trump Administration has announced four executive orders to lower drug prices, but health policy experts say they will likely offer patients only minimal relief and may take months to implement, if they're implemented at all.
Issues:Healthcare
July 14, 2020
Regarding “Virus Drug to Cost $3,120 Per Patient” (U.S. News, June 30):